Better blood sugar control GLP-1 medicines can lower HbA1c levels (a marker of average blood sugar over 3 months), helping to keep blood sugar levels within a normal range
Effects are typically incremental rather than immediate, and they depend on individual biology, dose exposure patterns, and baseline pigmentation
However, it does not seem to influence the frequency or peak levels of growth hormone pulses
Signs can include chronic fatigue, frequent colds or infections, and reduced physical endurance
Many patients hold a lower dose longer if appetite suppression is already effective or if side effects need more time to resolve
Efficacy of surfactant treatment in adult respiratory conditions is less well established, but studies point to a possible role in modulating the immune response in pulmonary disease (Wang et al